|Bid||32.27 x 900|
|Ask||32.28 x 800|
|Day's Range||32.13 - 33.14|
|52 Week Range||22.11 - 55.17|
|Beta (5Y Monthly)||0.99|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 08, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||47.75|
Orthofix announces FDA clearance and first patient implants of the FIREBIRD SI Fusion System for Low Back Pain.
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Jefferies 2020 Healthcare Conference on Tuesday, June 2, 2020 at 3:00 p.m. ET. The conference will be held in a virtual meeting format.
Orthofix Medical Inc., a global medical device company, today announced its sponsorship of Olympic Gold Medalist and Spine Patient Laura Wilkinson.
Joining me on the call today are President and Chief Executive Officer, Jon Serbousek; and Chief Financial Officer, Doug Rice. During this call, we'll be making forward-looking statements that involve risks and uncertainties.
Shares of Orthofix Medical (NASDAQ:OFIX) remained unaffected at $36.16 after the company reported Q1 results.Quarterly Results Earnings per share fell 66.67% over the past year to $0.09, which beat the estimate of $0.06.Revenue of $104,823,000 lower by 3.93% year over year, which missed the estimate of $105,860,000.Looking Ahead Orthofix Medical hasn't issued any earnings guidance for the time being.Orthofix Medical hasn't issued any revenue guidance for the time being.Conference Call Details Date: May 08, 2020View more earnings on OFIXWebcast URL: https://edge.media-server.com/mmc/p/qc9jp9anPrice Action 52-week high: $57.40Company's 52-week low was at $22.11Price action over last quarter: down 1.47%Company Description Orthofix Medical Inc is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The company has four reportable segments include Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. It generates maximum revenue from Bone Growth Therapies segment. Geographically, it generates maximum revenue from a company the U.S and also has a presence in Italy, Germany, United Kingdom, Brazil, and other countries.See more from Benzinga * Harsco: Q1 Earnings Insights * Recap: Mersana Therapeutics Q1 Earnings * Noble Midstream Partners: Q1 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Orthofix (OFIX) delivered earnings and revenue surprises of -18.18% and 0.31%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the first quarter ended March 31, 2020. Net sales were $104.8 million, diluted earnings per share ("EPS") was $1.32 and adjusted EPS was $0.09.
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Bank of America Securities 2020 Healthcare Virtual Conference on Thursday, May 14, 2020 at 1:00 p.m. ET.
NEW YORK, May 06, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Orthofix Medical Inc..
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the first quarter 2020 before market open on Friday, May 8, 2020. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.
Orthofix today announced preliminary financial results for the first quarter ended March 31, 2020 and provided a business update.
Orthofix Medical completes the acquisition of the FITBONE intramedullary lengthening system for limb lengthening of the femur and tibia bones.
Investors who take an interest in Orthofix Medical Inc. (NASDAQ:OFIX) should definitely note that the Independent...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm ...
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
Orthofix Medical Inc. (NASDAQ:OFIX) shareholders (or potential shareholders) will be happy to see that the Independent...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 29) Cabaletta Bio Inc (NASDAQ: CABA ) Edwards Lifesciences ...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Orthofix (OFIX) delivered earnings and revenue surprises of -21.15% and -4.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards a company. This time it may be different. During the fourth quarter of 2018 we observed increased volatility and small-cap stocks underperformed the […]
When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking...
In the near future, there is a probability of 3D-printed implantable organs becoming a reality, thereby increasing the number of lives saved.